At Nortem BioGroup, we value transparency and trust in our relationship with investors. In this Communication section, you will find relevant and up-to-date information on our company’s performance, important events, financial announcements and other significant news. We are committed to keeping you informed about our progress, strategies and results, providing easy and direct access to all the data you need to make informed investment decisions.
Date: June 30, 2025
Date: June 11, 2025
The shareholders of Nortem Chem S.A. are hereby summoned to the ordinary meeting to be held on June 28, 2025, with the exclusive agenda being the approval of the 2024 financial statements.
Date: March 12, 2025
The Board members are hereby summoned to meet on March 29 to prepare the 2024 annual accounts.
Date: November 18, 2024
The shareholders of Nortem Chem S.A. are hereby summoned to the extraordinary meeting to be held on December 20, 2024, with the exclusive agenda of approving the appointment of an auditor for the fiscal years 2024, 2025, and 2026 in favor of the audit firm AUDITORES PÁEZ SL.
Date: June 30, 2024
Nortem BioGroup Announces the Appointment of its New CEO
Date: July 10, 2024
Nortem BioGroup is pleased to announce the appointment of José Luis Vázquez as our new Chief Executive Officer (CEO), effective today.
José Luis Vázquez brings extensive experience and a strong track record of leadership. His strategic vision and commitment to innovation will be instrumental in guiding Nortem BioGroup through our next phase of growth and development.
Statement from the New CEO:
“It is an honor to join Nortem BioGroup as CEO. I am excited to work with this talented team to lead the company to new levels of success and to continue developing innovative solutions that improve the health and well-being of people around the world.”
We appreciate the continued support of our shareholders, employees, and partners as we move forward in this exciting phase of our history.
About Nortem BioGroup
Nortem BioGroup is a company dedicated to the research, development, and production of natural and organic products, focused on improving the health, well-being, and quality of life of its customers through bioinnovation and constant progress. Specializing in the food, cosmetics, and chemical industries, the company is distinguished by its commitment to creating unique and healthy products, backed by rigorous quality and control standards.
Nortem BioGroup is guided by a philosophy based on four essential pillars: innovation, sustainability, proximity, and awareness. The company constantly prioritizes bioinnovation as a driving force behind its advancements, focusing on preserving the health and well-being of its customers.
Date: June 21, 2024
The Board of Directors meeting is hereby convened at 8:00 a.m. on July 10, 2024, at the company's registered office. The meeting is to be held for the purpose of dismissing the current non-director secretary and revoking the current powers granted to the dismissed secretary. The meeting is also to be held for the appointment of the secretary of the board and the CEO.
Date: June 12, 2024
The shareholders of Nortem Chem S.A. are hereby summoned to the ordinary meeting to be held on June 28, 2024, with the exclusive agenda being the approval of the 2023 financial statements.
Date: March 12, 2024
The Board members are hereby summoned to meet on March 29 to prepare the 2024 annual accounts.
Date: June 30, 2025
Date: June 11, 2025
The shareholders of Nortem Chem S.A. are hereby summoned to the ordinary meeting to be held on June 28, 2025, with the exclusive agenda being the approval of the 2024 financial statements.
The directors are called to meet on 31 March to formulate the annual accounts for 2024.
Date: November 18, 2024
The shareholders of Nortem Chem S.A. are hereby summoned to the extraordinary meeting to be held on December 20, 2024, with the exclusive agenda of approving the appointment of an auditor for the fiscal years 2024, 2025, and 2026 in favor of the audit firm AUDITORES PÁEZ SL.
Nortem BioGroup announces the appointment of its new CEO
Date: July 10, 2024
Nortem BioGroup is pleased to announce the appointment of José Luis Vázquez as our new Chief Executive Officer (CEO), effective today.
José Luis Vázquez brings with him vast experience and a solid leadership track record. His strategic vision and commitment to innovation will be instrumental in guiding Nortem BioGroup through our next phase of growth and development.
Statement from the New CEO:
“It is an honor to join Nortem BioGroup as CEO. “I am excited to work with this talented team to take the company to new levels of success and to continue developing innovative solutions that improve the health and well-being of people around the world.”
We appreciate the continued support of our shareholders, employees and partners as we move forward through this exciting stage in our history.
About Nortem BioGroup
Nortem BioGroup is a company dedicated to the research, development and production of natural and ecological products, focused on improving the health, well-being and quality of life of its clients through bioinnovation and constant progress. Specialized in the food, cosmetic and chemical industry sectors, the company is distinguished by its commitment to creating unique and healthy products, backed by rigorous quality and control standards.
Nortem BioGroup is governed by a philosophy that is based on four essential pillars: innovation, sustainability, closeness and awareness. The company constantly prioritizes bioinnovation as a driving force for its advances, focusing on preserving the health and well-being of its customers.
Date: March 12, 2025
The Board members are hereby summoned to meet on March 29 to prepare the 2024 annual accounts.
Members are convened at 9.00 am. on 08 July 2024 at the registered office of the company to the extraordinary shareholders' meeting for the approval, if necessary, of the amendment of the Articles of Association to enable the issuance of non-voting shares.
The Board of Directors is convened at 8.00 a.m. on 08 July 2024 at the registered office of the company for the dismissal of the current secretary non-director and for the revocation of the current powers granted to the dismissed secretary. And for the appointment of the secretary of the board, and of the managing director.
The shareholders of Nortem Chem S.A. are hereby summoned to the ordinary meeting to be held on 28 June 2024, with the sole agenda of approving the accounts for 2023.